Inactive Instrument
Genomic Vision Share Price
Stocks
GV
FR0011799907
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Aaron Bensimon
CEO | Chief Executive Officer | - | 31/12/2005 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -10.00% | - | - | 727K | |
| -4.10% | -8.35% | +38.48% | +66.99% | 66.22B | |
| -0.41% | +3.27% | +10.46% | +73.74% | 55.2B | |
| +0.74% | +4.04% | +12.18% | +91.76% | 52.79B | |
| -0.46% | +1.65% | +26.47% | +49.98% | 45.53B | |
| -1.29% | +2.33% | +22.09% | +126.87% | 43.94B | |
| -3.98% | -0.50% | +255.45% | +925.99% | 41.64B | |
| -1.67% | +8.06% | +14.17% | +56.67% | 34B | |
| -8.38% | -9.01% | +25.65% | -1.82% | 25.84B | |
| +1.30% | +4.94% | +38.23% | +28.03% | 23.51B | |
| Average | -1.80% | +3.43% | +49.24% | +157.58% | 43.19B | |
| Weighted average by Cap. | -1.87% | +3.43% | +47.92% | +160.29% |
Employees
33
